subscribe: Posts | Comments

New Viagra Condom Encourages Safe Sex

0 comments
New Viagra Condom Encourages Safe Sex

An erection-aiding condom that men would actually want to wear…

A British biotech firm has created a new condom that increases blood flow to the penis to help erections last longer. The new condoms, dubbed the Viagra condoms, are specifically aimed at men who have problems maintaining an erection whilst wearing a condom, and are not a treatment for erectile dysfunction, note its developers.

Officially known as CSD500, the condoms do not actually contain Viagra, instead they are lined with a vasodilating gel, which increases blood flow to the penis.

Finding the active ingredient to help the penis stay erect was not a difficult task explained Futura Chief Executive James Barder:

“Its simply a generic compound for the treatment of angina, a severe chest pain caused by lack of blood flow to the heart.” [Time]

The clever science came in figure out how to get the gel to stay inside the condom so that it would only affect the wearer. Another major hurdle was to develop a substance that did not degrade the latex in anyway.

viagra condoms 550x412 New Viagra Condom Encourages Safe Sex

Viagra Condoms

Image Credit: robertelyov, 2010.

Keeping details to a minimum Mr. Barder said that adding the vasodilator to the lubricant is complicated, so complicated in fact that the company has taken out several patents to protect its method.

Marketing a condom that men actually wanted to wear would not only result in more men choosing to practice safer sex, it would also reduce the number of unwanted births that result from unprotected intercourse.

And aside from the obvious benefits of more men wanting to wear condoms, the CSD500’s could also help reduce the number of sexually transmitted infections that result from the condom slipping off due to erectile problems.

The drug developed by Futura Medical and licensed to the Durex brand, which is owned by consumer-products company Reckitt Benckiser, is very close to being approved in the U.K, and according to the Wall Street Journal, could be on the market within a year.

However, for the company to sell the condoms on the American market, it must first seek FDA approval; which will no doubt involve more clinical trials. Nevertheless, Reckitt Benckiser says it plans to investigate the condoms commercial viability in Europe, and if all goes well, will eventually expand to the U.S. market.


Comments are closed.